EGFR and breast carcinoma: In vitro studies clearly demonstrated that the targeted NNTA-QDs exhibited an affinity for EGFR-overexpressing breast cancer cells (4T1 and MDA-MB-231) and were readily internalized, whereas non-targeted NNTA-QDs showed no significant binding to breast cancer cells (Yang et al., 2009b).